CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells

Molecular Carcinogenesis

Volumn 50, Issue 10, 2011, Pages 804-810

  Chen, Xiong ^a   Mo, Ping ^a   Li, Xiaohua ^a   Zheng, Peichan ^b   Zhao, Lina ^a   Xue, Zengfu ^a   Ren, Gui ^a   Han, Guohong ^a   Wang, Xin ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b People's Hospital of Fujian Province   (China)

Author keywords

CacyBP SIP; Cell cycle; Pancreatic cancer; Proliferation

Indexed keywords

BINDING PROTEIN; CALCYCLIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN E; PROTEIN P27; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FLOW CYTOMETRY; G1 PHASE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; S PHASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80052282349     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20737     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363:1049-1057.
3. Chen R, Pan S, Brentnall TA, Aebersold R. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics 2005;4:523-533.
4. Filipek A, Kuznicki J. Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J Neurochem 1998;70:1793-1798.
5. Filipek A. Wojda, U. p30, a novel protein target of mouse calcyclin (S100A6). Biochem J 1996;320:585-587.
6. Matsuzawa SI, Reed JC. Siah-1, SIP, and, Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 2001;7:915-926.
7. Filipek A, Jastrzebska B, Nowotny M, Kuznicki J. CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J Biol Chem 2002;277:28848-28852.
8. Schneider G, Nieznanski K, Jozwiak J, Slomnicki LP, Redowicz MJ, Filipek A. Tubulin binding protein, CacyBP/SIP, induces actin polymerization and may link actin and tubulin cytoskeletons. Biochim Biophys Acta 2010;1803:1308-1317.
9. Kilanczyk E, Filipek S, Jastrzebska B, Filipek A. CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1. Biochem Biophys Res Commun 2009;380:54-59.
10. Xia ZB, Dai MS, Magoulas C, Broxmeyer HE, Lu L. Differentially expressed genes during in vitro differentiation of murine embryonic stem cells transduced with a human erythropoietin receptor cDNA. J Hematother Stem Cell Res 2000;9:651-658.
11. Pircher TJ, Geiger JN, Zhang D, Miller CP, Gaines P, Wojchowski DM. Integrative signaling by minimal erythropoietin receptor forms and c-Kit. J Biol Chem 2001;276:8995-9002.
12. Au KW, Kou CY, Woo AY, et al. Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes. J Cell Biochem 2006;98:555-566.
13. Matigian N, Windus L, Smith H, et al. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol Psychiatry 2007;12:815-825.
14. Zhao Y, You H, Liu F, et al. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002;185:211-218.
15. Shi Y, Hu W, Yin F, et al. Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP). Gastric Cancer 2004;7:160-166.
16. Ning X, Sun S, Hong L, et al. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res 2007;5:1254-1262.
17. Sun S, Ning X, Liu J, et al. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem Biophys Res Commun 2007;356:864-871.
18. Chen X, Han G, Zhai H, et al. Expression and clinical significance of CacyBP/SIP in pancreatic cancer. Pancreatology 2008;8:470-477.
19. Schneider G, Filipek A. S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): Spotlight on properties and cellular function. Amino Acids 2010.
20. Zhai H, Shi Y, Yu J, et al. Establishment and characterization of calcyclin binding protein (CacyBP) monoclonal antibody. Hybridoma (Larchmt) 2006;25:91-94.
21. Zhai H, Shi Y, Jin H, et al. Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: An immunohistochemical survey. J Histochem Cytochem 2008;56:765-772.
22. Assinder SJ, Au E, Dong Q, Winnick C. A novel splice variant of the beta-tropomyosin (TPM2) gene in prostate cancer. Mol Carcinog 2010;49:525-531.
23. Li Y, Liu J, Li Q. Mechanisms by which the antitumor compound di-n-butyl-di-(4-chlorobenzohydroxamato)tin(IV) induces apoptosis and the mitochondrial-mediated signaling pathway in human cancer SGC-7901 cells. Mol Carcinog 2010;49:566-581.
24. Milner AE, Levens JM, Gregory CD. Flow cytometric methods of analyzing apoptotic cells. Methods Mol Biol 1998;80:347-354.
25. Perez M, Regan T, Pflug B, Lynch J, Djakiew D. Loss of low-affinity nerve growth factor receptor during malignant transformation of the human prostate. Prostate 1997;30(4) 274-279.
26. Geldof AA, Van Haarst EP, Newling DW. Neurotrophic factors in prostate and prostatic cancer. Prostate Cancer Prostatic Dis 1998;1(5) 236-241.
27. Miller FD, Kaplan DR. Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci 2001;58(8) 1045-1053.
28. Khwaja F, Tabassum A, Allen J, Djakiew D. The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells. Biochem Biophys Res Commun 2006;341(4) 1184-1192.
29. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13(12) 1501-1512.